Long-term urinary quality of life after permanent prostate brachytherapy (Q53301791)

13 May 2018

title

Long-term urinary quality of life after permanent prostate brachytherapy (English)

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04600-X

31 December 2023

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04600-X

31 December 2023

author name string

Gregory S. Merrick

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738320

31 December 2023

Wayne M. Butler

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738320

31 December 2023

Kent E. Wallner

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738320

31 December 2023

Robert W. Galbreath

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738320

31 December 2023

Jonathan H. Lief

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12738320

31 December 2023

language of work or name

English

0 references

publication date

1 June 2003

1 reference

13 May 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S036030160204600X?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04600-X

https://api.elsevier.com/content/article/PII:S036030160204600X?httpAccept=text/plain

31 December 2023

1 reference

https://api.crossref.org/works/10.1016/S0360-3016(02)04600-X

International Journal of Radiation Oncology Biology Physics

31 December 2023

published in

1 reference

13 May 2018

volume

56

1 reference

13 May 2018

issue

2

1 reference

13 May 2018

page(s)

454-461

1 reference

13 May 2018

Permanent interstitial brachytherapy for the management of carcinoma of the prostate gland

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Patient reported complications after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Temporal resolution of urinary morbidity following prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Identification of patients at increased risk for prolonged urinary retention following radioactive seed implantation of the prostate.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Relationship between the transition zone index of the prostate gland and urinary morbidity after brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Prophylactic versus therapeutic alpha-blockers after permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

The dosimetry of prostate brachytherapy-induced urethral strictures

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Dysuria after permanent prostate brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Gross hematuria after prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Prostate brachytherapy in patients with prostate volumes >/= 50 cm(3): dosimetic analysis of implant quality

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Long-term urinary function after transperineal brachytherapy for patients with large prostate glands

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Comprehensive comparison of health-related quality of life after contemporary therapies for localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

LONG-TERM TREATMENT RELATED COMPLICATIONS OF BRACHYTHERAPY FOR EARLY PROSTATE CANCER: A SURVEY OF PATIENTS PREVIOUSLY TREATED

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Accuracy of recall in health-related quality-of-life assessment among men treated for prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Development and validation of the expanded prostate cancer index composite (EPIC) for comprehensive assessment of health-related quality of life in men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Comparison of seed loading approaches in prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Dosimetry of interstitial brachytherapy sources: recommendations of the AAPM Radiation Therapy Committee Task Group No. 43. American Association of Physicists in Medicine.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Correlation of smoking history and other patient characteristics with major complications of pelvic radiation therapy for cervical cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Quality of life after prostate cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Quality-of-life comparison of radical prostatectomy and interstitial brachytherapy in the treatment of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

I-125 versus Pd-103 for low-risk prostate cancer: morbidity outcomes from a prospective randomized multicenter trial

1 reference

https://api.crossref.org/works/10.1016%2FS0360-3016%2802%2904600-X

7 January 2021

Identifiers

1 reference

13 May 2018

1 reference

13 May 2018